nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RY2—cardiovascular system—attention deficit hyperactivity disorder	0.0319	0.0689	CbGeAlD
Suramin—SIRT5—forebrain—attention deficit hyperactivity disorder	0.0233	0.0504	CbGeAlD
Suramin—SIRT5—cardiovascular system—attention deficit hyperactivity disorder	0.0197	0.0426	CbGeAlD
Suramin—SIRT1—forebrain—attention deficit hyperactivity disorder	0.0193	0.0417	CbGeAlD
Suramin—FSHR—cerebellum—attention deficit hyperactivity disorder	0.0181	0.0392	CbGeAlD
Suramin—SIRT1—cardiovascular system—attention deficit hyperactivity disorder	0.0163	0.0353	CbGeAlD
Suramin—RYR1—cardiovascular system—attention deficit hyperactivity disorder	0.0151	0.0326	CbGeAlD
Suramin—SIRT1—midbrain—attention deficit hyperactivity disorder	0.0127	0.0276	CbGeAlD
Suramin—SIRT5—nervous system—attention deficit hyperactivity disorder	0.0126	0.0273	CbGeAlD
Suramin—SIRT5—central nervous system—attention deficit hyperactivity disorder	0.0122	0.0263	CbGeAlD
Suramin—P2RX4—nervous system—attention deficit hyperactivity disorder	0.012	0.0259	CbGeAlD
Suramin—SIRT5—cerebellum—attention deficit hyperactivity disorder	0.0119	0.0257	CbGeAlD
Suramin—RYR1—midbrain—attention deficit hyperactivity disorder	0.0118	0.0255	CbGeAlD
Suramin—P2RX4—central nervous system—attention deficit hyperactivity disorder	0.0115	0.0249	CbGeAlD
Suramin—PLA2G2A—cardiovascular system—attention deficit hyperactivity disorder	0.0114	0.0247	CbGeAlD
Suramin—P2RX4—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0243	CbGeAlD
Suramin—SIRT1—nervous system—attention deficit hyperactivity disorder	0.0105	0.0227	CbGeAlD
Suramin—ARSA—nervous system—attention deficit hyperactivity disorder	0.0103	0.0224	CbGeAlD
Suramin—SIRT1—central nervous system—attention deficit hyperactivity disorder	0.0101	0.0218	CbGeAlD
Suramin—ARSA—central nervous system—attention deficit hyperactivity disorder	0.00996	0.0215	CbGeAlD
Suramin—SIRT1—cerebellum—attention deficit hyperactivity disorder	0.00986	0.0213	CbGeAlD
Suramin—ARSA—cerebellum—attention deficit hyperactivity disorder	0.00974	0.0211	CbGeAlD
Suramin—RYR1—nervous system—attention deficit hyperactivity disorder	0.00968	0.0209	CbGeAlD
Suramin—SIRT5—brain—attention deficit hyperactivity disorder	0.00967	0.0209	CbGeAlD
Suramin—RYR1—central nervous system—attention deficit hyperactivity disorder	0.00932	0.0202	CbGeAlD
Suramin—P2RX4—brain—attention deficit hyperactivity disorder	0.00914	0.0198	CbGeAlD
Suramin—RYR1—cerebellum—attention deficit hyperactivity disorder	0.00911	0.0197	CbGeAlD
Suramin—PLA2G2A—midbrain—attention deficit hyperactivity disorder	0.00892	0.0193	CbGeAlD
Suramin—F2—cardiovascular system—attention deficit hyperactivity disorder	0.00863	0.0187	CbGeAlD
Suramin—SIRT1—brain—attention deficit hyperactivity disorder	0.00801	0.0173	CbGeAlD
Suramin—PLA2G4A—cardiovascular system—attention deficit hyperactivity disorder	0.00795	0.0172	CbGeAlD
Suramin—ARSA—brain—attention deficit hyperactivity disorder	0.00791	0.0171	CbGeAlD
Suramin—RYR1—brain—attention deficit hyperactivity disorder	0.0074	0.016	CbGeAlD
Suramin—PLA2G2A—nervous system—attention deficit hyperactivity disorder	0.00734	0.0159	CbGeAlD
Suramin—PLA2G2A—central nervous system—attention deficit hyperactivity disorder	0.00706	0.0153	CbGeAlD
Suramin—PLA2G4A—midbrain—attention deficit hyperactivity disorder	0.00621	0.0134	CbGeAlD
Suramin—PLA2G2A—brain—attention deficit hyperactivity disorder	0.00561	0.0121	CbGeAlD
Suramin—F2—nervous system—attention deficit hyperactivity disorder	0.00554	0.012	CbGeAlD
Suramin—F2—central nervous system—attention deficit hyperactivity disorder	0.00533	0.0115	CbGeAlD
Suramin—PLA2G4A—nervous system—attention deficit hyperactivity disorder	0.0051	0.011	CbGeAlD
Suramin—PLA2G4A—central nervous system—attention deficit hyperactivity disorder	0.00491	0.0106	CbGeAlD
Suramin—F2—brain—attention deficit hyperactivity disorder	0.00423	0.00915	CbGeAlD
Suramin—PLA2G4A—brain—attention deficit hyperactivity disorder	0.0039	0.00843	CbGeAlD
Suramin—P2RY2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00309	0.00575	CbGpPWpGaD
Suramin—SIRT1—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00304	0.00566	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00304	0.00566	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00303	0.00563	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00299	0.00557	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00298	0.00555	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00293	0.00544	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00289	0.00538	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00283	0.00527	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00283	0.00526	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00282	0.00525	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00279	0.00518	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00275	0.00512	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00274	0.0051	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00274	0.00509	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00271	0.00504	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00269	0.00501	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00266	0.00494	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00265	0.00493	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00257	0.00479	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00256	0.00477	CbGpPWpGaD
Suramin—SIRT1—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00255	0.00475	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00248	0.00461	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00244	0.00453	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—EP300—attention deficit hyperactivity disorder	0.00243	0.00453	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00242	0.00451	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0024	0.00446	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00235	0.00438	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00231	0.00431	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00228	0.00425	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00224	0.00416	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00223	0.00415	CbGpPWpGaD
Suramin—SIRT1—p73 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00221	0.00411	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0022	0.0041	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00216	0.00402	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00216	0.00402	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00215	0.004	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00212	0.00395	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0021	0.0039	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0021	0.0039	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00208	0.00388	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00386	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00205	0.00381	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00203	0.00378	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00202	0.00376	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00202	0.00376	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.00201	0.00374	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.002	0.00372	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.002	0.00372	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00196	0.00365	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00195	0.00363	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00188	0.00351	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00183	0.00341	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00183	0.0034	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0018	0.00334	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00176	0.00328	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00173	0.00323	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00172	0.0032	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00155	0.00288	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.00282	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0015	0.00278	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00148	0.00276	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00142	0.00265	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00141	0.00262	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00138	0.00256	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00137	0.00254	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00136	0.00253	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00136	0.00253	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00135	0.00252	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00132	0.00246	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00132	0.00245	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00131	0.00243	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00128	0.00239	CbGpPWpGaD
Suramin—ARSA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.00234	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00126	0.00234	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00229	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00122	0.00228	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00122	0.00227	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00122	0.00226	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0012	0.00223	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.00223	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00119	0.00221	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00118	0.0022	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00118	0.0022	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00118	0.00219	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00118	0.00219	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00116	0.00216	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00116	0.00215	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00115	0.00215	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00114	0.00213	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00114	0.00213	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00114	0.00211	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00113	0.0021	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00111	0.00206	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0011	0.00205	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0011	0.00205	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00109	0.00203	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00203	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00108	0.002	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00107	0.00199	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00107	0.00198	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00196	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00196	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00105	0.00195	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00104	0.00193	CbGpPWpGaD
Suramin—F2—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00103	0.00192	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00103	0.00191	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.001	0.00186	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000972	0.00181	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000967	0.0018	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000962	0.00179	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000944	0.00176	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000899	0.00167	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000883	0.00164	CbGpPWpGaD
Suramin—ARSA—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00087	0.00162	CbGpPWpGaD
Suramin—ARSA—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00087	0.00162	CbGpPWpGaD
Suramin—ARSA—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000856	0.00159	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000841	0.00157	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000836	0.00156	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000831	0.00155	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000824	0.00153	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000812	0.00151	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00081	0.00151	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000808	0.0015	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000803	0.00149	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000796	0.00148	CbGpPWpGaD
Suramin—ARSA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000796	0.00148	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000786	0.00146	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000784	0.00146	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000775	0.00144	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000772	0.00144	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000746	0.00139	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000732	0.00136	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000727	0.00135	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000702	0.00131	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000701	0.00131	CbGpPWpGaD
Suramin—ARSA—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000695	0.00129	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000693	0.00129	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000685	0.00127	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000678	0.00126	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000676	0.00126	CbGpPWpGaD
Suramin—ARSA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000662	0.00123	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000654	0.00122	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000652	0.00121	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000652	0.00121	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000643	0.0012	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000639	0.00119	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000637	0.00118	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000635	0.00118	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000632	0.00118	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000621	0.00116	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000617	0.00115	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000613	0.00114	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000606	0.00113	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000599	0.00111	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000592	0.0011	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000592	0.0011	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00058	0.00108	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000571	0.00106	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000561	0.00104	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000561	0.00104	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000558	0.00104	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000551	0.00103	CbGpPWpGaD
Suramin—F2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000542	0.00101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000542	0.00101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000531	0.000987	CbGpPWpGaD
Suramin—ARSA—Metabolism—COMT—attention deficit hyperactivity disorder	0.000527	0.000981	CbGpPWpGaD
Suramin—ARSA—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000523	0.000974	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000522	0.00097	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000513	0.000954	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000513	0.000954	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000508	0.000944	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000496	0.000922	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000477	0.000888	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000448	0.000834	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000443	0.000824	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000427	0.000794	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000414	0.000771	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000407	0.000758	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000402	0.000748	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.0004	0.000745	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000391	0.000727	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000387	0.00072	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000383	0.000712	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000372	0.000693	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000369	0.000687	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000368	0.000684	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00036	0.00067	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000351	0.000654	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00035	0.000651	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000349	0.000648	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000343	0.000638	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.000637	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—COMT—attention deficit hyperactivity disorder	0.00034	0.000632	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000338	0.000629	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000337	0.000627	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000336	0.000625	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000327	0.000608	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000327	0.000608	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000321	0.000598	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00032	0.000595	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000316	0.000589	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000315	0.000586	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000313	0.000583	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000579	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000307	0.000572	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000307	0.000572	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000299	0.000556	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000289	0.000539	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000286	0.000533	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000529	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000281	0.000523	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000264	0.000491	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000264	0.000491	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000262	0.000487	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.000483	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000449	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000238	0.000442	CbGpPWpGaD
Suramin—ARSA—Metabolism—EP300—attention deficit hyperactivity disorder	0.000226	0.000421	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000221	0.000411	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00022	0.000408	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000217	0.000404	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000212	0.000395	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000211	0.000393	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000208	0.000386	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000374	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.0002	0.000373	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000193	0.000359	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00019	0.000353	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000187	0.000348	CbGpPWpGaD
Suramin—F2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000185	0.000344	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000184	0.000342	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000183	0.000341	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000181	0.000338	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000177	0.000328	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000171	0.000318	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000169	0.000315	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000169	0.000315	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.000313	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000166	0.000309	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000298	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.000296	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000155	0.000288	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000154	0.000287	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000146	0.000271	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000118	0.00022	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000108	0.000202	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—EP300—attention deficit hyperactivity disorder	6.86e-05	0.000128	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.27e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.74e-05	0.000107	CbGpPWpGaD
